Safety and efficacy of epoprostenol (PGI2) versus heparin (H) in hemodialysis (HD).
D004305:Dose-Response Relationship, Drug; D011464:Epoprostenol / Q000627:therapeutic use*; D005260:Female; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D007676:Kidney Failure, Chronic / Q000628:therapy*; D008297:Male; D010974:Platelet Aggregation / Q000187:drug effects; D006435:Renal Dialysis
D006493:Heparin; D011464:Epoprostenol